Immunoadjuvant
Mostrando 1-12 de 35 artigos, teses e dissertações.
-
1. Obtenção e caracterização de frações purificadas de saponinas de chenopodium quinoa e avaliação da formação de complexos do tipo iscom : atividades biológicas das frações e dos complexos formados
Chenopodium quinoa (quinoa) seeds are a rich protein source and well-known for their high saponin content. Chemically, quinoa saponins are triterpene glycosides being phytolaccagenic, hederagenin, oleanolic and serjanic acids the most common aglycones found in seeds. Its immunoadjuvant properties have been examined and the results obtained were conflicting.
IBICT - Instituto Brasileiro de Informação em Ciência e Tecnologia. Publicado em: 2011
-
2. Arranjos supramoleculares de oligodeoxinucleotídeos e fragmentos de bicamada catiônica: preparação, caracterização e atividade imunoadjuvante / Supramolecular assemblies of oligodeoxynucleotides and cationic bilayer fragments: preparation, characterization and immunoadjuvant activity
A interação entre fragmentos de bicamada (BF) de brometo de dioctadecildimetilamônio (DODAB) e um mononucleotídeo-modelo (deoxiadenosina monofosfato, dAMP) ou um oligodeoxinucleotídeo-modelo (5- AAAAAAAAAA-3, poli(dA)) ou um oligodeoxinucleotídeo terapêutico (5- TTGACGTTCG -3, CpG) foi investigada por turbidimetria, espalhamento de luz dinâmico, espe
Publicado em: 2011
-
3. Saponinas dos frutos de ilex paraguariensis A. St. Hil. (mate) : desenvolvimento de metodologia analítica, estudos físico-químico e biológico
O presente trabalho teve por objetivo a avaliação físico-química e biológica de uma fração de saponinas enriquecida, obtida a partir de frutos verdes de Ilex paraguariensis A. St. Hil (mate). A espécie apresenta grande importância econômica para vários países sul-americanos, dentre eles o Brasil. Os frutos verdes da espécie acumulam significativ
Publicado em: 2010
-
4. Construction and evaluation of rLTB/Sm14: a recombinant chimera candidate vaccine against schistosomiasis and fascioliasis / Construção e avaliação da rLTB/SM14 : uma quimera recombinante candidata a uma vacina contra esquistossomose e fasciolose
Schistosomiasis, caused by Schistosoma mansoni, is the second most prevalent parasitic disease worldwide causing chronic disease in millions of people in developing countries. Similarly, fascioliasis, caused by the trematode Fasciola hepatica, represents a recognized unsolved agricultural problem responsible for economic losses as well as causing a significa
Publicado em: 2006
-
5. Interactions between cationic liposomes and drugs or biomolecules
Multiple uses for synthetic cationic liposomes composed of dioctadecyldimethylammonium bromide (DODAB) bilayer vesicles are presented. Drugs or biomolecules can be solubilized or incorporated in the cationic bilayers. The cationic liposomes themselves can act as antimicrobial agents causing death of bacteria and fungi at concentrations that barely affect mam
Anais da Academia Brasileira de Ciências. Publicado em: 2000-03
-
6. In Vivo Expression and Immunoadjuvancy of a Mutant of Heat-Labile Enterotoxin of Escherichia coli in Vaccine and Vector Strains of Vibrio cholerae
Vibrio cholerae secretes cholera toxin (CT) and the closely related heat-labile enterotoxin (LT) of Escherichia coli, the latter when expressed in V. cholerae. Both toxins are also potent immunoadjuvants. Mutant LT molecules that retain immunoadjuvant properties while possessing markedly diminished enterotoxic activities when expressed by E. coli have been d
American Society for Microbiology.
-
7. Immunization by an insoluble fraction extracted from Brucella melitensis: immunological and chemical characterization of the active substances.
A peptidoglycan-containing fraction called fraction P.I. (phenol insoluble), extracted from Brucella melitensis and previously described by some of us, had immunogenic and protective properties and did not produce any allergic reactions. Since it is well known that bacterial peptidoglycans studied so far have immunoadjuvant properties, the isolation of the a
-
8. Biological Study of a Nontoxic, Water-Soluble Immunoadjuvant from Mycobacterial Cell Walls
Whole mycobacterial cells, which are used in Freund's complete adjuvant, besides inducing hypersensitivity to tuberculoprotein, also can elicit hyperreactivity to endotoxins, lymphoid hyperplasia, and allergic polyarthritis in rats. The data reported here demonstrate that a potent water-soluble adjuvant obtained from mycobacterial cell walls is also effectiv
-
9. In vitro and in vivo comparisons of amphotericin B and N-D-ornithyl amphotericin B methyl ester.
N-D-Ornithyl amphotericin B methyl ester (N-D-ornithyl AmE) has a lower toxicity for animals than does amphotericin B (AmB), and peak serum levels can be achieved that are fourfold higher than those obtained with an equivalent dose of AmB. However, N-D-ornithyl AmE has one-fourth the in vitro activity and between one-fifth and one-eighth the in vivo activity
-
10. Oral immunization with attenuated vaccine strains of Vibrio cholerae expressing a dodecapeptide repeat of the serine-rich Entamoeba histolytica protein fused to the cholera toxin B subunit induces systemic and mucosal antiamebic and anti-V. cholerae antibody responses in mice.
Entamoeba histolytica is a significant cause of morbidity and mortality worldwide. The serine-rich E. histolytica protein (SREHP) is a surface-expressed trophozoite protein that includes multiple hydrophilic tandem repeats. A purified fusion protein between the dodecapeptide repeat of SREHP and cholera toxin B subunit (CTB) has previously been shown to be im
-
11. Immunoadjuvant activity of amphotericin B as displayed in mice infected with Candida albicans.
Mice receiving a single intraperitoneal injection of amphotericin B showed increased resistance to subsequent challenge with either Candida albicans or Staphylococcus aureus. This enhancement of resistance was obvious in terms of both survival criteria and clearance of the intravenously injected organism from different organs. The protective effect of amphot
-
12. Enhancement of the neonate's nonspecific immunity to Klebsiella infection by muramyl dipeptide, a synthetic immunoadjuvant.
N-acetylmuramyl-L-alanyl-D-isoglutamine (muramyl dipeptide) and certain derivatives that are structural analogs of part of the bacterial peptidoglycan monomer have been shown to be adjuvant active and to enhance the nonspecific immunity of adult mice infected by Klebsiella pneumoniae. In the present study muramyl dipeptide and two other synthetic analogs wer